Norgine Europe BV provides pharmaceutical products. It offers products for acute and chronic illnesses, including gastroenterology, hepatology, incontinence and pain management. The company was founded in 1906 and is headquartered in Amsterdam, the Netherlands.

Guangdong Jiabo Pharmaceutical Co., Ltd., established on 2003-10-20, Business scope includes production and sales of large volume injections,small volume injection,Freeze-dried powder injection,API(Propofol,Rocuronium Bromide,Methoxamine hydrochloride,Glycopyrrolate,flurbiprofen axetil,micuronium chloride),Manufacturing of Veterinary Drugs(Involving countries prohibiting or restricting production,Except for medicines sold);Import and export of goods or technology;Healthy food(prepackaged)Sales;food sales(Only sell prepackaged food);Food Internet Sales(Only sell prepackaged food).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Zhejiang Jinhua New Materials Co., Ltd., established on 2007-12-27, Business scope includes isobutoxyethylene(intermediate product),Solid Hydroxylamine Sulfate,Hydroxylamine hydrochloride,Butanone oxime production,120#Solvent oil(Solvent recovery),toluene(Recycle)(With valid<safety production license>operate);Chlorine resin production,Sales;Chemical technology research and development and consulting;Chemical Products(Free of hazardous chemicals and precursor chemicals),building materials,Lubricant sales;foreign investment;Import and export(law,Except where restricted by law,Those who should obtain a license operate with a license);Loading and unloading service(Except for the licensing system);The business place of the branch is located at Luyin Road, Quzhou City38No,acetone oxime,Methyltributanoximinosilane,Methyltrimethoxysilane,Modified Methyltributanoximinosilane,Vinyl tributylketoxime silane,By-product ammonium chloride production,Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Norgine is a European specialist pharmaceutical company with a direct commercial presence in all major European markets. They operate a well-established European infrastructure to develop, manufacture and commercialise products.

Anhui Jinxuan Technology Co., Ltd., established on 2017-12-01, The business scope includes annual production of thionyl chloride4tons,Furfural1tons,Annual by-product hydrochloric acid(31%)800Production and sales of tons(Operate with safety production license,The license is valid for2020year9moon8to2023year9moon7day);food,drinks,food additives,Production and sales of food flavors;Products in the field of biotechnology,Production Process,Application Technology,Equipment research and development,Production,Sales;Maltol,ethyl maltol,Potassium sorbate,Corn flour,flour,Production of Sucralose,Sales;Jiale musk solution,Production and sales of furan ammonium salt.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

TRACON develops targeted therapies for cancer utilizing a capital efficient, CRO independent, product development platform. The Company’s clinical-stage pipeline includes: Envafolimab, a PD-L1 single-domain antibody given by rapid subcutaneous injection that is being studied in the pivotal ENVASARC trial for sarcoma; TRC102, a Phase 2 small molecule drug candidate for the treatment of lung cancer; and TJ004309, a CD73 antibody in Phase 1 development for the treatment of advanced solid tumors. TRACON is actively seeking additional corporate partnerships whereby it leads U.S. regulatory and clinical development, shares in the cost and risk of clinical development, and leads U.S. commercialization. In these partnerships TRACON believes it can serve as a solution for companies without clinical and commercial capabilities in the United States.

Jiangsu Qingquan Chemical Co., Ltd., established on 2005-05-28, Business scope includes licensed projects:Hazardous Chemical Production;Technology Import and Export;Import and export;Import and export agency(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Chemical product production(No licensed chemical products);Chemical product sales(No licensed chemical products);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Edenbridge is a specialty pharmaceutical company focused on identifying, developing, and marketing prescription pharmaceutical products. The company's goal is to create a broad portfolio of limited source branded and generic pharmaceutical products that will provide high-quality, affordable, and accessible alternatives in the healthcare market. Founded in 2008, launched its first product in February 2010 and currently sell its commercial products through every major channel of the U.S. prescription pharmaceutical supply chain. In addition, the company has a robust product development pipeline that includes ANDAs and 505(b)(2)s, and has successfully developed, filed, and received FDA approval for several products.

Shandong Jincheng Kerui Chemical Co. Ltd., a subsidiary of Shandong Jincheng Pharmaceutical Group Co., Ltd., is a company headquartered in Zibo, China, that manufactures chemical products. Xue Bo Zhang is the current CEO of the firm.

Galderma Research & Development SNC discovers, develops, and markets therapeutic, corrective, and aesthetic solutions. The company is headquartered in Biot, France.

Galderma SA develops and markets therapeutic and aesthetic solutions for dermatology. It provides medical dermatological solutions for acne, rosacea, psoriasis and other steroid-responsive dermatoses, onychomycosis, pigmentary disorders, skin cancer and medical aesthetic and corrective solutions for skin senescence. The company was founded in 1981 and is headquartered in Paris, France.

Xindongwei (Tianjin) Technology Co., Ltd., established on 2019-02-19, Business scope includes scientific research and technical service industry;business services;Wholesale and retail trade.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Galderma Pharma SA discovers, develops, and markets therapeutic, corrective, and aesthetic solutions. It offers drugs, medical dermatology solutions, and therapeutic skin care products for treating hair, nail, and skin diseases. The company was founded in 1981 and is headquartered in Lausanne, Switzerland.

Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany.

Shandong Jincheng Pharmaceutical Chemical Co., Ltd., established on 2017-04-05, Business scope includes general items:Manufacturing of basic chemical raw materials(Manufacture of licensed chemicals free of hazardous chemicals);refinery,Manufacture of special equipment for chemical production;Biochemical product technology research and development;Chemical product production(No licensed chemical products);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Environmental Protection Monitoring;Recycling of renewable resources(Removal of productive scrap metal)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Hazardous Chemical Production;pharmaceutical production;Various construction activities;Import and export;Technology Import and Export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Ningbo Siming Chemical Co., Ltd., established on 2004-07-07, Business scope includes liquid ammonia,crude methanol,hydrogen peroxide,carbon dioxide,hydrogen,industrial gas,Industrial ammonia,sulfur production,save;liquid ammonia,Carbon dioxide filling(Mobile pressure vessel filling);Syngas;oxygen(liquefied),nitrogen(liquefied)production and sales(The above projects are operated with valid licenses);ammonium bicarbonate,Manufacture of food additives,processing,save,operate;Methoxyamine hydrochloride,tert-butanol(Recycle),toluene(Recycle)production(Species licensed under a safety production license for hazardous chemicals);Manufacture of Organic Intermediates,Research,to develop,wholesale,retail;Research on new chemical materials,to develop;Hazardous Waste Management;Sewage Treatment Services;steam,hot water,Production and supply of heat;Self-operated and agent import and export business of various goods and technologies,Except for goods and technologies that are restricted by the state or prohibited from import and export;and other legal,regulations,Projects that are not prohibited or do not require operating permits and projects that are not included in the negative list of local industrial development in the decision of the State Council.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Xinfa Pharmaceutical Co. Ltd. is a Chinese private company located in Dongying. The firm manufactures spices and related products.

Takeda Pharmaceutical Company Ltd (武田薬品工業株式会社 Takeda Yakuhin Kōgyō Kabushiki-gaisha) is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following merger with Shire). The company has over 30,000 employees worldwide and achieved 16.2 billion USD in revenue during the 2012 fiscal year. The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary, Takeda Oncology. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States.

Sunflower Pharmaceutical Group Hubei Wudang Co., Ltd., established on 2008-01-23, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Drug retail;Drug import and export;Health food production;food production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:production of agricultural products,Sales,processing,transportation,Storage and other related services;real estate herbal medicine(Does not contain Chinese herbal medicine)buy and sell(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

Zhejiang Saite Membrane Technology Co., Ltd., established on 2011-03-14, Business scope includes services:Membrane separation,Purification technology development;Wholesale and retail:Membrane separation equipment,Equipment,energy saving equipment,Water treatment equipment and accessories.***